Literature DB >> 14576652

Infliximab for the treatment of hidradenitis suppurativa.

Benjamin Lebwohl1, Allen N Sapadin.   

Abstract

We describe a patient with hidradenitis suppurativa whose lesions responded to the administration of infliximab for suspected Crohn's disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14576652     DOI： 10.1016/s0190-9622(03)01132-0

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  6 in total

1.  Comorbidities of hidradenitis suppurativa (acne inversa).

Authors:  Sabine Fimmel; Christos C Zouboulis
Journal:  Dermatoendocrinol       Date:  2010-01

Review 2.  Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association.

Authors:  Mariabeatrice Principi; Nicoletta Cassano; Antonella Contaldo; Andrea Iannone; Giuseppe Losurdo; Michele Barone; Mario Mastrolonardo; Gino Antonio Vena; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 3.  Management of cutaneous disorders related to inflammatory bowel disease.

Authors:  Zaira Pellicer; Jesus Manuel Santiago; Alejandro Rodriguez; Vicent Alonso; Rosario Antón; Marta Maia Bosca
Journal:  Ann Gastroenterol       Date:  2012

Review 4.  Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Authors:  Shi Yu Derek Lim; Hazel H Oon
Journal:  Biologics       Date:  2019-05-13

Review 5.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

Review 6.  Hidradenitis Suppurativa: Inside and Out.

Authors:  Sharmila Patil; Astuty Apurwa; Nitin Nadkarni; Shweta Agarwal; Parag Chaudhari; Manjyot Gautam
Journal:  Indian J Dermatol       Date:  2018 Mar-Apr       Impact factor: 1.494
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.